Trial no.:
|
PACTR201605001635250 |
Date of Approval:
|
17/05/2016 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
scalp block for tissue expander surgery |
Official scientific title |
Selective scalp nerve block: An adjuvant technique with tissue expansion in post-burn pediatric alopecia. |
Brief summary describing the background
and objectives of the trial
|
SNB provides hemodynamic stability when performed with general anesthesia and may result in less supplemental intravenous or volatile anesthetics as it attenuates the sympathetic stimulation and surgical stress response (7, 8, 9). SNB provides postoperative analgesia and greatly reduces the need for opioids during the first 24 hours postoperatively for procedures such as awake craniotomies, insertion of the skull pins, awake stereotactic surgery and plastic procedures of the scalp with extensive dissection of the myocutaneous tissue. SNB was been successfully utilized in children .
For SNB, anatomical identification of the nerves will be done by bony landmarks palpation . SNB is easy to perform and has a minimal risk of side effects with expert hands (7).
As with any regional block; there is a risk associated with applying the local anesthetic includes intravascular injection and infection at the site of injection . Specific complications of SNB include neurologic deficits such permanent nerve damage, due to unintentional injection of local anesthetic directly into the nerve. Additionally, temporally motor facial nerve block could occur specifically during auriculotemporal nerve block due to paralysis of the facial muscles which will be reversed completely after the expected duration of action of the used local anesthetic. Those complications could be prevented by using the proper technique, avoid deeper infiltration than the bony landmark (epically above the zygoma) and injection of the recommended amount of local anesthetic .
In this study a comparison between preoperative bilateral SNB and no intervention will be done before scalp tissue expander insertion for burn-induced hair loss. The primary goal is the efficacy of postoperative analgesia with the hypothesis that; SNB will have more intraoperative hemodynamic stability, less intraoperative blood loss and less postoperative analgesic doses during the first 24 hours.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
,Anaesthesia,Paediatrics,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
04/11/2015 |
Actual trial start date |
04/11/2015 |
Anticipated date of last follow up |
01/06/2016 |
Actual Last follow-up date |
01/06/2016 |
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Recruiting |
Publication URL |
no url yet |
|